Nov 24, 2023 · In this multicentre, double-blind, placebo-controlled, phase II clinical trial, we randomise patients with GBA-PD in a 1:1 ratio to either oral ...

Feb 18, 2020 · Ambroxol shows promise, and warrants further investigation ― including conducting larger, placebo-controlled trials.

Jan 13, 2020 · The study results suggest that ambroxol therapy was safe and well tolerated; CSF penetration and target engagement of ambroxol were achieved, ...

Clinical trial results support ambroxol and other GCase enhancers as a promising treatment to halt the progression of Parkinson's. Find out more.

Ambroxol hydrochloride is a pharmacological chaperone approved by FDA as an expectorant. Currently, it is used as an antitussive and anti-asthmatic agent.

Mar 12, 2023 · Ambroxol Dosage. Adults: daily dose of 30 mg (one Ambroxol tablet ) ... Children over 5 years: One teaspoonful Ambroxol syrup 2-3 times daily.

Ambroxol is indicated for secretolytic therapy in bronchoplmonary disease with abnormal mucus secretion and transport. It allows the mucus to be more easily ...

Apr 22, 2021 · Ambroxol is a mucolytic compound and the main ingredient of over-the-counter cough medicines sold in many countries. Syrup, tablet, and other ...